Human
Basic Research
Development
Preclinical Trials
Clinical Trials
Human
Human
Animal
GF-1002 –Suspension of AAV vector for intravenous infusion, containing CDNA of centenarian variant of SIRT6
Phase I/II Werner Syndrome
Phase I/II idiopathic Pulmonary Fibrosis
Pivotal trial anti-aging for dogs with vet partner
Phase I/II Werner Syndrome
GF-2001 – Inhaled formulation for idiopathic Pulmonary Fibrosis
GF-3001 – Topical delivery of SIRT6 to the skin
GF-4001- Non-Human Pipeline Anti-aging for Veterinary use (dogs)